CNBX Pharmaceuticals (CNBX Pharmaceuticals) FCF Yield % : -59.63 (As of May. 15, 2024)

View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, CNBX Pharmaceuticals's Trailing 12-Month Free Cash Flow is $-0.20 Mil, and Market Cap is $0.33 Mil. Therefore, CNBX Pharmaceuticals's FCF Yield % for today is -59.63%.

The historical rank and industry rank for CNBX Pharmaceuticals's FCF Yield % or its related term are showing as below:

CNBX' s FCF Yield % Range Over the Past 10 Years
Min: -2173.54 Med: -8.95 Max: -0.05
Current: -59.63

During the past 13 years, the highest FCF Yield % of CNBX Pharmaceuticals was -0.05%. The lowest was -2173.54%. And the median was -8.95%.

CNBX's FCF Yield % is ranked worse than
77.73% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs CNBX: -59.63

CNBX Pharmaceuticals's FCF Margin % for the quarter that ended in Feb. 2024 was -302.44%.

CNBX Pharmaceuticals FCF Yield % Historical Data

The historical data trend for CNBX Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals FCF Yield % Chart

CNBX Pharmaceuticals Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

FCF Yield %

Get a 7-Day Free Trial

-9.44

-11.05

-9.87

-39.30

-29.57

CNBX Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
FCF Yield %	Get a 7-Day Free Trial															-35.28	-22.90	21.98	-85.95	-132.86

Competitive Comparison of CNBX Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, CNBX Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNBX Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's FCF Yield % falls into.

CNBX Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

CNBX Pharmaceuticals's FCF Yield % for the fiscal year that ended in Aug. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.113	/	0.38213097
	=	-29.57%

CNBX Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Feb. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.124	*	4	/	0.3733356
	=	-132.86%

CNBX Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

CNBX Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

CNBX Pharmaceuticals (CNBX Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814

Website

https://www.cnbxpharma.com

CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the RCC-33, an oral capsule for the treatment of colorectal cancer. The company tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.

Executives

Cannabics Inc.	10 percent owner	108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills	director, officer: President, CEO, CFO
North American Mining Corp	10 percent owner	6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford	director, officer: Vice-President, Secretary